- Global Pharma News & Resources

Radiopharmaceuticals Market 2020-2027 Sets the Table for Continued Growth | Global Players – General Electric Company, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.p.A., Nordion Inc

A DBMR team makes use of simple language and easy to understand statistical images to provide thorough information and in-depth data on the industry and Global Radiopharmaceuticals Market. The company profiles of all the key players and brands that are dominating the market have been taken into consideration here. The report also shares gross margin, market share, attractiveness index, and value and volume growth of all of the segments studied by the analysts. The report provides players with crucial information and suggests result-oriented tactics to gain a competitive edge in the worldwide market. Important industry trends, market size, market share estimates are analysed and mentioned in the Global Radiopharmaceuticals Market research report.

What’s more, Global Radiopharmaceuticals Market report assesses each segment of the global market in a very detailed pattern so that readers can be informed about future opportunities and high-growth areas of the industry. This Global Radiopharmaceuticals Market report makes you focus on the more important aspects of the market like what the market recent trends are. Besides, it offers a complete study of crucial market dynamics, including growth drivers, restraints, challenges, trends, and opportunities. Readers are presented with accurate facts and figures related to the market and its significant factors such as consumption, production, revenue growth, and CAGR.

Get Sample Report + All Related Graphs & Charts @

The global radiopharmaceuticals market is expected to rise to an estimated value of USD 11.85 billion by 2026 registering a substantial CAGR of 9.30% in the forecast period of 2019-2026. In the rise in market can be attributed to increasing prevalence of cancer and cardiovascular chronic diseases, rising health expenditure and technological advancements.

Key Market Competitors: Global Radiopharmaceuticals Market

Few of the major market competitors currently working in the radiopharmaceuticals market are Cardinal Health, Mallinckrodt., General Electric Company, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.p.A., Nordion Inc., Advanced Accelerator Applications, Surgery Theater, Positron Corporation, NTP, IsoPET, Eli Lilly and Company., Jubilant Pharma. LLC, Actinium Pharmaceuticals, Inc., Immunomedics, Inc., Areva Pharma, Merck & Co., Inc., Navidea Biopharmaceuticals, Inc., Eckert & Ziegler., Siemens Healthcare Private Limited, Novartis AG, Curium, among others.

Owing to the upsurge in the prevalence of cardiovascular chronic diseases and cancer radiopharmaceuticals market is expected to bring in USD 11.85 billion by 2026.  The increasing rate of chronic diseases and its diagnosis and treatment in the early stages of cancer is driving the market growth of the radiopharmaceuticals market across the world.

Due to this progression the market is expected to propel by 9.30% of annual growth rate in the forecasted period of 2019 to 2026. The accelerating initiative adopted by government and healthcare sector for providing sustainable radiopharmaceuticals services will propel the market growth in the expected time frame.

Radiopharmaceuticals Market Scenario

According to Data Bridge Market Research the market for radiopharmaceuticals is booming with the rising expenditure in the healthcare solutions. The demand of technological elevations and progress which authorizes the practice of monoclonal antibodies and radio-labeled peptides for the operation and diagnosis of carcinogenic cysts and augmenting inclination towards PET and SPECT scan and gaining bent towards virus targeted tumor therapeutics is expected to accelerate the growth of radiopharmaceuticals market in the anticipated time phase.

The rising demand of healthcare sector integration with the boosting expenditure on the research and development of radiopharmaceuticals and rising familiarity of the same amidst emerging nations will increase the share stocks and market value of radiopharmaceuticals market. Few of the factors will acts as restraint to curb down the market growth such as rigorous administrative guidelines and tremendous expense of tools using radioisotopes will hamper the market growth. Also the undersized life expectancy of radiopharmaceutical will hinder the growth of radiopharmaceuticals market.

Now the question is which are the other regions that radiopharmaceuticals market is targeting? Data Bridge Market Research has forecasted a large growth in Asia-Pacific (APAC) region due to the increment in health tourism, the increasing rate of healthcare sector will also create a deep crater for market growth of radiopharmaceuticals market. North America is expected to dominate the global share and market due to advanced healthcare cost system and germinating cancer and cardiovascular chronic diseases.

Grab Your Report at an Impressive 30% Discount! Please click Here @

Radiopharmaceuticals Market Development and Acquisitions in 2019

  • In December 2019, a significant development was accounted for the expansion of radiopharmaceuticals exchange between Curium and Finnish. Curium has accomplished the purchase of Finnish Radiopharmaceuticals Corporation of MAP medical technologies Oy. This merger of MAP Medical will moreover extend Curium’s trail in Europe, rendering straight entrance to Nordic and Baltic realms for its comprehensive holdings of diagnostic resolutions.

Key Pointers Covered in the Radiopharmaceuticals Market Industry Trends and Forecast to 2026

  • Market Size
  • Market New Sales Volumes
  • Market Replacement Sales Volumes
  • Market Installed Base
  • Market By Brands
  • Market Procedure Volumes
  • Market Product Price Analysis
  • Market Healthcare Outcomes
  • Market Cost of Care Analysis
  • Market Regulatory Framework and Changes
  • Market Prices and Reimbursement Analysis
  • Market Shares in Different Regions
  • Recent Developments for Market Competitors
  • Market Upcoming Applications
  • Market Innovators Study

Get Free Detailed TOC @

Radiopharmaceuticals Market Scope

The Radiopharmaceuticals Market is segmented on the basis of countries into U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

  • All country based analysis of the radiopharmaceuticals market is further analyzed based on maximum granularity into further segmentation. On the basis type, radiopharmaceuticals market is segmented into diagnostic nuclear medicine, therapeutic nuclear medicine. On the basis of application, the radiopharmaceuticals market is fragmented into diagnostic, and therapeutic. On the procedural volume, market is bifurcated into diagnostic procedures, therapeutic procedures. On the basis of source, the market is segmented into nuclear reactors, cyclotrons. On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, diagnostic centers, cancer research institutes, others.
  • Radiopharmaceuticals are an accumulation of pharma medicine which has radiation intact in them. It can be adopted as a remedial agent. Radiopharmaceuticals are unusual therapeutic formulations comprising radioactive isotopes which are practiced in significant clinical section for analysis or treatment.

Key Market Competitors Covered in the report

  • Cardinal Health
  • Mallinckrodt
  • General Electric Company
  • Lantheus Medical Imaging, Inc
  • Bayer AG
  •  Bracco Imaging S.p.A
  • Nordion (Canada) Inc
  • Advanced Accelerator Applications
  • Surgery Theater
  • Positron Corporation
  • NTP
  • IsoPET
  • Eli Lilly and Company
  • Jubilant Pharma LLC
  •  Actinium Pharmaceuticals Inc
  •  Immunomedics, Inc
  •  Areva Pharma
  • Merck & Co Inc
  •  Navidea Biopharmaceuticals Inc
  • Eckert & Ziegler
  •  Siemens Healthcare Private Limited
  •  Novartis AG
  •  Curium

For More Insights Get FREE Detailed TOC @

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.


Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475


This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 21-Oct-2020